CHO Plus, Inc. ( a leading developer of biopharmaceutical manufacturing technology, announces that U.S. Patent No. 12,270,055 ...

Bo Wang is a renowned AI scientist at the University of Toronto. He’s bringing his open-source culture and computational ...

China has approved its first gene therapy for hemophilia B, an inherited bleeding disorder caused by the deficiency of ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Xaira Therapeutics today announced the appointment of Dr. Bo Wang as SVP and Head of Biomedical AI. In this role, Dr. Wang will lead the company's efforts to develop AI-driven models to help elucidate ...

IDT and Elegen partner to launch an early access program offering long, clonal gene synthesis and high-complexity genes up to ...

When exposed to antibiotics, approximately one out of every 10 8 -10 9 bacteria develops resistance due to spontaneous ...

“As we advance toward the clinic, we have made the decision to redesign the structure of our team ... firm on the path toward bankruptcy. Viral-vector-focused Ring Therapeutics and cell ...

Pilgrim's Pride shows strong growth potential with global chicken demand and automation support. Find out why PPC stock is a ...